{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:38:40Z","timestamp":1769845120223,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.clon.2006.10.006","type":"journal-article","created":{"date-parts":[[2006,11,21]],"date-time":"2006-11-21T14:53:44Z","timestamp":1164120824000},"page":"135-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Challenges in Treating Patients with Down's Syndrome and Testicular Cancer with Chemotherapy and Radiotherapy: The Royal Marsden Experience"],"prefix":"10.1016","volume":"19","author":[{"given":"S.","family":"Hafeez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Huddart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.P.","family":"Dearnaley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Horwich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2006.10.006_bib1","series-title":"Forfar and Arneil's textbook of pediatrics","year":"2003"},{"key":"10.1016\/j.clon.2006.10.006_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1192\/bjp.95.400.685","article-title":"The incidence of Mongolism in the general population","volume":"95","author":"Penrose","year":"1949","journal-title":"J Ment Sci"},{"key":"10.1016\/j.clon.2006.10.006_bib3","first-page":"603","article-title":"Life expectancy of persons with Down's syndrome","volume":"95","author":"Eyman","year":"1991","journal-title":"Am J Ment Retard"},{"key":"10.1016\/j.clon.2006.10.006_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1469-8749.2004.tb00483.x","article-title":"Clinical, social and ethical implications of changing life expectancy in Down syndrome","volume":"46","author":"Bittles","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.clon.2006.10.006_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1017\/S0012162205000319","article-title":"Mortality and causes of death in persons with Down syndrome in California","volume":"47","author":"Day","year":"2005","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.clon.2006.10.006_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(00)00435-6","article-title":"Pattern of malignant disorders in individuals with Down's syndrome","volume":"2","author":"Hasle","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2006.10.006_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/(SICI)1097-0142(19970901)80:5<929::AID-CNCR14>3.0.CO;2-Y","article-title":"An excess of testicular germ cell tumours in Down's syndrome: three case reports and a review of the literature","volume":"80","author":"Satage","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2006.10.006_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0022-5347(17)41492-3","article-title":"Genetic abnormalities in men with germ cell tumours","volume":"140","author":"Dexeus","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2006.10.006_bib9","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0022-5347(01)64838-9","article-title":"Association of Down's syndrome and testicular cancer","volume":"157","author":"Diekermann","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2006.10.006_bib10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0025-6196(12)60660-0","article-title":"Malignant potential of the cryptoorchid testis","volume":"66","author":"Benson","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clon.2006.10.006_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1006\/gyno.1999.5453","article-title":"Trisomy 21 associated with ovarian dysgerminoma","volume":"74","author":"Smucker","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clon.2006.10.006_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.humpath.2005.09.021","article-title":"Maturation delay of germ cell in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumours","volume":"37","author":"Cools","year":"2006","journal-title":"Human Pathol"},{"key":"10.1016\/j.clon.2006.10.006_bib13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bmj.308.6941.1393","article-title":"Aetiology of testicular cancer; association with congenital abnormalities, age at puberty, infertility and exercise","volume":"308","author":"Forman","year":"1994","journal-title":"Br Med J"},{"key":"10.1016\/j.clon.2006.10.006_bib14","first-page":"54","article-title":"The possible role of sex hormones in the development of testicular cancer","volume":"23","author":"Meyts","year":"1993","journal-title":"Eur Urol"},{"key":"10.1016\/j.clon.2006.10.006_bib15","first-page":"1407","article-title":"Testicular tumours","volume":"Vol. 2","author":"Horwich","year":"1995"},{"key":"10.1016\/j.clon.2006.10.006_bib16","first-page":"1203","article-title":"Testicular seminoma and Down's syndrome","volume":"8","author":"Roberge","year":"2001","journal-title":"Can J Urol"},{"key":"10.1016\/j.clon.2006.10.006_bib17","series-title":"Down's syndrome: the psychology of Mongolism","author":"Gibson","year":"1978"},{"key":"10.1016\/j.clon.2006.10.006_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00005053-199110000-00004","article-title":"Psychiatric disorders in a population with Down's syndrome","volume":"179","author":"Myers","year":"1991","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.clon.2006.10.006_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000179141","article-title":"Gonadal function in trisomy 21","volume":"12","author":"Hasen","year":"1980","journal-title":"Horm Res"},{"key":"10.1016\/j.clon.2006.10.006_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/01485019308987740","article-title":"Hormone profiles and contralateral testicular histology in Down's syndrome with unilateral testicular tumor","volume":"30","author":"Sasagawa","year":"1993","journal-title":"Arch Androl"},{"key":"10.1016\/j.clon.2006.10.006_bib21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.2005.08.003","article-title":"Randomized trial of 30 versus 20Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organization for the Research and Treatment of Cancer trial 30942","volume":"23","author":"Jones","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2006.10.006_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(05)66984-X","article-title":"Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomized trial","volume":"366","author":"Oliver","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2006.10.006_bib23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(06)68305-0","article-title":"Testicular germ cell cancer","volume":"367","author":"Horwich","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2006.10.006_bib24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1259\/0007-1285-68-808-400","article-title":"Radiotherapy for stages I and II testicular seminoma; results and morbidity in 238 patients","volume":"68","author":"Vallis","year":"1995","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2006.10.006_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1200\/JCO.1998.16.1.290","article-title":"Management of stage II seminoma","volume":"16","author":"Warde","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2006.10.006_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0360-3016(01)01701-1","article-title":"Radiotherapy for stage II testicular seminoma","volume":"51","author":"Zagars","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2006.10.006_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0167-8140(00)00240-1","article-title":"Combination of carboplatin and radiotherapy in the management of stage II testicular seminoma; comparison with radiotherapy treatment alone","volume":"59","author":"Patterson","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2006.10.006_bib28","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2004.01.020","article-title":"Stage II testicular seminoma: patterns of recurrence and outcome of treatment","volume":"45","author":"Chung","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.clon.2006.10.006_bib29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(03)12987-X","article-title":"Down's syndrome","volume":"361","author":"Roizen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2006.10.006_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.2000.02027.x","article-title":"The management of neoplastic disorders of haematopoiesis in children with Down's syndrome","volume":"110","author":"Lange","year":"2000","journal-title":"Br J Haematol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655506004079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655506004079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:30:40Z","timestamp":1760542240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655506004079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0936655506004079"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2006.10.006","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in Treating Patients with Down's Syndrome and Testicular Cancer with Chemotherapy and Radiotherapy: The Royal Marsden Experience","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2006.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}